IN DATAPowered by Inside the dealDeals analysisRankingsEconomic dataMacro-economic indicatorsINSIDE THE DEALAstraZeneca and Fusion team up on targeted alpha therapiesFusion and AstraZeneca are partnering to develop next-generation cancer treatmentsDeals AnalysisNorth America deals volume up 4% YoYNorth America is leading in terms of deal value, but recorded the lowest YoY growth in deals volume at 4%RankingsWho's leading Japan's R&D expenditure?Our pharma industry key list brings you the 15 leading companies in Japan by R&D expenditureInside the dealDeals analysisRankingsEconomic dataMacro-economic indicators02/24/2024 10:38:19
Inside the deal
Deals analysis
Rankings
Economic data
Macro-economic indicators